儿童甲状腺结节:结合临床危险因素的K-TIRADS/ACR TI-RADS儿童特异性活检阈值
该研究回顾性分析2010年1月至2021年12月首尔国立大学医院200例儿童(中位年龄16岁)的223个活检证实甲状腺结节,评估结合危险因素的儿童特异性活检阈值对2021 K-TIRADS和ACR TI-RADS诊断性能的改善。结果显示,对伴危险因素的4类结节及所有5类结节采用0.5 cm活检阈值可提高两种系统的敏感度和降低漏诊恶性率。
要点
- 儿童甲状腺结节恶性率高于成人,但缺乏儿童特异性活检阈值。
- 对伴危险因素的4类结节及所有5类结节采用0.5 cm阈值可提高K-TIRADS和ACR TI-RADS敏感度。
- 临床与超声表现不一致的儿童甲状腺结节需重复活检。
核心结论
- 对伴危险因素的4类结节及所有5类结节采用0.5 cm活检阈值可改善两种系统的诊断性能,临床与超声表现不一致的儿童甲状腺结节需重复活检。
研究设计与样本
- 回顾性分析2010年1月至2021年12月首尔国立大学医院200例患者(中位年龄16岁,IQR 13-18岁;153例女性;17例儿童年龄<10岁,183例青少年年龄10-19岁;92例有危险因素)的223个活检证实甲状腺结节(142个恶性结节,占全部结节的64%,占166个切除结节的86%)。
诊断标准与关键数值
- 改良K-TIRADS/ACR TI-RADS儿童特异性活检阈值:伴危险因素的4类结节为0.5 cm,不伴危险因素的4类结节为1.5 cm,所有5类结节为0.5 cm。K-TIRADS敏感度85%(121/142)vs 78%(111/142),漏诊恶性率33%(21/64)vs 39%(31/79),均P < .005和P < .05。ACR TI-RADS敏感度84%(119/142)vs 60%(85/142),漏诊恶性率30%(23/76)vs 46%(57/122),均P < .005和P < .05;准确率74%(164/223)vs 71%(159/223),P = .30;77%(172/223)vs 67%(150/223),P = .002。
临床应用与阅片要点
- 对伴危险因素(桥本甲状腺炎、既往放疗、甲状腺癌家族史或遗传性肿瘤综合征)的4类结节及所有5类结节采用0.5 cm活检阈值;对临床与超声表现不一致的儿童甲状腺结节进行重复活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Pediatric thyroid nodules have a higher malignancy rate than adult nodules; yet, a pediatric-specific biopsy cutoff is lacking. Purpose To investigate the usefulness of repeat biopsy and a pediatric-specific biopsy cutoff incorporating risk factors to improve the diagnostic performance of the 2021 Korean Thyroid Imaging Reporting and Data System (K-TIRADS) and American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS). Materials and Methods US images of biopsy-confirmed pediatric thyroid nodules obtained at Seoul National University Hospital between January 2010 and December 2021 were retrospectively analyzed. The diagnostic performance of the aforementioned systems with the incorporation of risk factors (Hashimoto thyroiditis, previous radiation therapy, family history of thyroid cancer, or hereditary tumor syndrome) was evaluated. The McNemar test and the weighted generalized score statistic were used. Results Two hundred patients (median age, 16 years [IQR, 13-18 years]; 153 female; 17 children [age, <10 years] and 183 adolescents [age, 10-19 years]; 92 with risk factors) with 223 nodules (142 malignant nodules [64% of total nodules; 86% of 166 resected nodules]) were analyzed. Repeat biopsies owing to large size, interval growth, or category 4 and 5 revealed that six of 21 nodules (29%) initially categorized as benign were malignant postoperatively. Compared with the current guidelines, a modified K-TIRADS/ACR TI-RADS pediatric-specific biopsy cutoff (0.5 cm and 1.5 cm for category 4 nodules with and without risk factors, respectively, and 0.5 cm for all category 5 nodules) improved the sensitivity (85% [121 of 142] vs 78% [111 of 142] for K-TIRADS; 84% [119 of 142] vs 60% [85 of 142] for ACR TI-RADS; both P < .005) and missed malignancy rate (33% [21 of 64] vs 39% [31 of 79]; 30% [23 of 76] vs 46% [57 of 122]; both P < .05) for both systems and accuracy for ACR TI-RADS (74% [164 of 223] vs 71% [159 of 223]; 77% [172 of 223] vs 67% [150 of 223]; P = .30 and P = .002, respectively). Conclusion Applying a 0.5-cm biopsy cutoff in pediatric patients improved diagnostic performance for both category 4 nodules with risk factors and category 5 nodules. Repeat biopsy was required for pediatric thyroid nodules with discordant clinical and US findings. © RSNA, 2025 Supplemental material is available for this article.
引用
- Lee DH, Cho YJ, Won JK, et al. Pediatric Thyroid Nodules: K-TIRADS/ACR TI-RADS Pediatric-Specific Biopsy Cutoff Incorporating Clinical Risk Factors. Radiology. 2025. PMID: 40525973. doi:10.1148/radiol.241015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。